Robert Hindes, MD, a former group director of virology for Bristol-Myers Squibb, currently serves as the chief medical officer for Trek Therapeutics, a drug manufacturer focusing on treatments for infectious diseases. Under the leadership of Robert Hindes, MD, Trek Therapeutics is developing highly effective and affordable combination regimens to treat Hepatitis C (HCV), a blood-borne infectious disease.
We just sent you an email. Please click the link in the email to confirm your subscription!
OKSubscriptions powered by Strikingly